drugset / Trial / NCT03393520
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in participants with dementia of the Alzheimer's type.
Timeline
- Start
- 2017-10-13
- Primary completion
- 2023-11-17
- Completion
- 2023-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deudextromethorphan | Unknown | — | Oral |
| Subject | Quinidine | Small molecule | — | Oral |
Indications
No indication recorded.